Search Results - "Bourlière, Marc"

Sofosbuvir, Velpatasvir, and Voxilaprevir for Previously Treated HCV Infection by Bourlière, Marc, Gordon, Stuart C, Flamm, Steven L, Cooper, Curtis L, Ramji, Alnoor, Tong, Myron, Ravendhran, Natarajan, Vierling, John M, Tran, Tram T, Pianko, Stephen, Bansal, Meena B, de Lédinghen, Victor, Hyland, Robert H, Stamm, Luisa M, Dvory-Sobol, Hadas, Svarovskaia, Evguenia, Zhang, Jie, Huang, K.C, Subramanian, G. Mani, Brainard, Diana M, McHutchison, John G, Verna, Elizabeth C, Buggisch, Peter, Landis, Charles S, Younes, Ziad H, Curry, Michael P, Strasser, Simone I, Schiff, Eugene R, Reddy, K. Rajender, Manns, Michael P, Kowdley, Kris V, Zeuzem, Stefan

“…In two trials involving patients with hepatitis C in whom previous treatment with direct-acting antiviral agents failed, treatment for 12 weeks with…”
Get full text

Sofosbuvir and Velpatasvir for HCV Genotype 2 and 3 Infection by Foster, Graham R, Afdhal, Nezam, Roberts, Stuart K, Bräu, Norbert, Gane, Edward J, Pianko, Stephen, Lawitz, Eric, Thompson, Alex, Shiffman, Mitchell L, Cooper, Curtis, Towner, William J, Conway, Brian, Ruane, Peter, Bourlière, Marc, Asselah, Tarik, Berg, Thomas, Zeuzem, Stefan, Rosenberg, William, Agarwal, Kosh, Stedman, Catherine A.M, Mo, Hongmei, Dvory-Sobol, Hadas, Han, Lingling, Wang, Jing, McNally, John, Osinusi, Anu, Brainard, Diana M, McHutchison, John G, Mazzotta, Francesco, Tran, Tram T, Gordon, Stuart C, Patel, Keyur, Reau, Nancy, Mangia, Alessandra, Sulkowski, Mark

“…In two phase 3 trials involving patients with hepatitis C virus infection, including those with cirrhosis, 12 weeks of sofosbuvir–velpatasvir resulted in a…”
Get full text

Increased mortality in HIV/HCV-coinfected compared to HCV-monoinfected patients in the DAA era due to non-liver-related death by Chalouni, Mathieu, Pol, Stanislas, Sogni, Philippe, Fontaine, Hélène, Lacombe, Karine, Marc-Lacombe, Jean, Esterle, Laure, Dorival, Celine, Bourlière, Marc, Bani-Sadr, Firouzé, de Ledinghen, Victor, Zucman, David, Larrey, Dominique, Salmon, Dominique, Carrat, Fabrice, Wittkop, Linda, Salmon, D., Wittkop, L., Sogni, P., Esterle, L., Trimoulet, P., Izopet, J., Serfaty, L., Paradis, V., Spire, B., Carrieri, P., Valantin, M.A., Pialoux, G., Chas, J., Poizot-Martin, I., Barange, K., Naqvi, A., Rosenthal, E., Bicart-See, A., Bouchaud, O., Gervais, A., Lascoux-Combe, C., Goujard, C., Lacombe, K., Duvivier, C., Neau, D., Morlat, P., Bani-Sadr, F., Meyer, L., Boufassa, F., Autran, B., Roque, A.M., Solas, C., Fontaine, H., Costagliola, D., Piroth, L., Simon, A., Zucman, D., Boué, F., Miailhes, P., Billaud, E., Aumaitre, H., Rey, D., Peytavin, G., Petrov-Sanchez, V., Lebrasseur-Longuet, D.

“…Direct-acting antivirals (DAA) lead to high sustained virological response (SVR) rates and decrease the risk of disease progression. We compared SVR rates and…”
Get full text

Nomogram for individualized prediction of hepatocellular carcinoma occurrence in hepatitis C virus cirrhosis (ANRS CO12 CirVir) by Ganne‐Carrié, Nathalie, Layese, Richard, Bourcier, Valérie, Cagnot, Carole, Marcellin, Patrick, Guyader, Dominique, Pol, Stanislas, Larrey, Dominique, Lédinghen, Victor, Ouzan, Denis, Zoulim, Fabien, Roulot, Dominique, Tran, Albert, Bronowicki, Jean‐Pierre, Zarski, Jean‐Pierre, Riachi, Ghassan, Calès, Paul, Péron, Jean‐Marie, Alric, Laurent, Bourlière, Marc, Mathurin, Philippe, Blanc, Jean‐Frédéric, Abergel, Armand, Serfaty, Lawrence, Mallat, Ariane, Grangé, Jean‐Didier, Attali, Pierre, Bacq, Yannick, Wartelle, Claire, Dao, Thông, Benhamou, Yves, Pilette, Christophe, Silvain, Christine, Christidis, Christos, Capron, Dominique, Bernard‐Chabert, Brigitte, Zucman, David, Di Martino, Vincent, Trinchet, Jean‐Claude, Nahon, Pierre, Roudot‐Thoraval, Françoise

“…The aim of this work was to develop an individualized score for predicting hepatocellular carcinoma (HCC) in patients with hepatitis C (HCV)‐compensated…”
Get full text

Sorafenib: Experience and Better Manage­ment of Side Effects Improve Overall Survival in Hepatocellular Carcinoma Patients: A Real-Life Retrospective Analysis by Raoul, Jean-Luc, Adhoute, Xavier, Penaranda, Guillaume, Perrier, Hervé, Castellani, Paul, Oules, Valérie, Bourlière, Marc

“…Background: Sorafenib is the first-line treatment for advanced hepatocellular carcinoma (HCC). The management of its side effects is improving. This study…”
Get full text

Extrahepatic cancers are the leading cause of death in patients achieving hepatitis B virus control or hepatitis C virus eradication by Allaire, Manon, Nahon, Pierre, Layese, Richard, Bourcier, Valérie, Cagnot, Carole, Marcellin, Patrick, Guyader, Dominique, Pol, Stanislas, Larrey, Dominique, De Lédinghen, Victor, Ouzan, Denis, Zoulim, Fabien, Roulot, Dominique, Tran, Albert, Bronowicki, Jean‐Pierre, Zarski, Jean‐Pierre, Riachi, Ghassan, Calès, Paul, Péron, Jean‐Marie, Alric, Laurent, Bourlière, Marc, Mathurin, Philippe, Blanc, Jean‐Frédéric, Abergel, Armand, Serfaty, Lawrence, Mallat, Ariane, Grangé, Jean‐Didier, Attali, Pierre, Bacq, Yannick, Wartelle, Claire, Dao, Thông, Thabut, Dominique, Pilette, Christophe, Silvain, Christine, Christidis, Christos, Nguyen‐Khac, Eric, Bernard‐Chabert, Brigitte, Zucman, David, DI Martino, Vincent, Sutton, Angela, Letouzé, Eric, Audureau, Etienne, Roudot‐Thoraval, Françoise

“…Data on extrahepatic cancers (EHCs) in compensated viral cirrhosis are limited. The objective of the prospective multicenter Agence Nationale de Recherche sur…”
Get full text

New anti HCV drugs in the pipeline by Bourlière, Marc

Get full text

Severe liver failure rather than cirrhosis is associated with mortality in patients with infectious endocarditis: a retrospective case–control study by Allaire, Manon, Cadranel, Jean-François D, Bureau, Christophe, Zerkly, Salah, Thévenot, Thierry, Garioud, Armand, Cacoub, Patrice, Macaigne, Gilles, Alric, Laurent, Jouannaud, Vincent, Lison, Hortensia, Chagneau-Derrode, Carine, Pariente, Alexandre, Pe[Combining Acute Accent]laquier, Agne[Combining Grave Accent]s, Bourlie[Combining Grave Accent]re, Marc, Causse, Xavier, Nousbaum, Jean-Baptiste, Dumortier, Je[Combining Acute Accent]rôme, Louvet, Alexandre, Rosa-He[Combining Acute Accent]zode, Isabelle, Ganne-Carrie[Combining Acute Accent], Nathalie, Chentouh, Ryme, Sfaxi, Anis, Gournay, Je[Combining Acute Accent]rome, Blasco-Perrin, He[Combining Acute Accent]le[Combining Grave Accent]ne, Antonini, Teresa, Spahr, Laurent, Bronowicki, Jean-Pierre, Silvain, Christine, Di Martino, Vincent, Grange, Jean-Didier, Denis, Jacques, Dupont, Karine, Iaria, Pierre, Ollivier-Hourmand, Isabelle, Dao, Thong

“…BACKGROUNDData on infectious endocarditis (IE) in patients with liver cirrhosis (LC) are sparse. We aimed to describe the characteristics and predictors of…”
Get full text

Occult Hepatitis C Virus Infection Revisited with Ultrasensitive Real-Time PCR Assay by Halfon, Philippe, Bourlière, Marc, Ouzan, Denis, Sène, Damien, Saadoun, David, Khiri, Hacène, Pénaranda, Guillaume, Martineau, Agnes, Oulès, Valérie, Cacoub, Patrice

“…Occult hepatitis C infection is regarded as a new entity that should be considered when diagnosing patients with a liver disease of unknown origin. Using an…”
Get full text

Usefulness of the MESH score in a European hepatocellular carcinoma cohort by Adhoute, Xavier, Pénaranda, Guillaume, Raoul, Jean-Luc, Bourlière, Marc

“…The Barcelona Clinic Liver Cancer classification is the most widely-used hepatocellular carcinoma(HCC) staging system because it is simple,precise and linked…”
Get full text

Women and liver: Is woman the future of man? by Bourlière, Marc

Get full text

Hepatitis C Virus by Asselah, Tarik, MD, PhD, Bourlière, Marc, MD

“…Hepatitis C virus (HCV) is a major cause of chronic liver disease, with more than 170 million infected individuals worldwide. Genotype 4 is the most frequent…”
Get full text

Retreatment of HCV with ABT-450/r–Ombitasvir and Dasabuvir with Ribavirin by Zeuzem, Stefan, Jacobson, Ira M, Baykal, Tolga, Marinho, Rui T, Poordad, Fred, Bourlière, Marc, Sulkowski, Mark S, Wedemeyer, Heiner, Tam, Edward, Desmond, Paul, Jensen, Donald M, Di Bisceglie, Adrian M, Varunok, Peter, Hassanein, Tarek, Xiong, Junyuan, Pilot-Matias, Tami, DaSilva-Tillmann, Barbara, Larsen, Lois, Podsadecki, Thomas, Bernstein, Barry

“…In this trial in patients with HCV genotype 1 infection and no cirrhosis who had previously been treated with peginterferon and ribavirin, retreatment with…”
Get full text

Hepatitis C virus therapy: No one will be left behind by Bourlière, Marc, Pietri, Olivia

“…•Direct-acting antiviral agents (DAAs) has dramatically improved HCV treatment.•All combinations since 2014 achieved a cure rates over 95% with a good safety…”
Get full text

Impact of cirrhosis aetiology on incidence and prognosis of hepatocellular carcinoma diagnosed during surveillance by Ganne-Carrié, Nathalie, Nahon, Pierre, Chaffaut, Cendrine, N’Kontchou, Gisèle, Layese, Richard, Audureau, Etienne, Chevret, Sylvie, Ganne-Carrié, Nathalie, Chaffaut, Cendrine, Archambeaud, Isabelle, d’Alteroche, Louis, Oberti, Frédéric, Roulot, Dominique, Moreno, Christophe, Louvet, Alexandre, Dao, Thông, Moirand, Romain, Goria, Odile, Nguyen-Khac, Eric, Carbonell, Nicolas, Duclos-Vallée, Jean-Charles, Pol, Stanislas, de Ledinghen, Victor, Ozenne, Violaine, Henrion, Jean, Péron, Jean-Marie, Tran, Albert, Perlemuter, Gabriel, Amiot, Xavier, Zarski, Jean-Pierre, Chevret, Sylvie, Nahon, Pierre, Asselah, Tarik, Guyader, Dominique, Pol, Stanislas, Fontaine, Hélène, Pageaux, Georges-Philippe, De Lédinghen, Victor, Ouzan, Denis, Zoulim, Fabien, Roulot, Dominique, Tran, Albert, Bronowicki, Jean-Pierre, Decaens, Thomas, Riachi, Ghassan, Calès, Paul, Péron, Jean-Marie, Alric, Laurent, Bourlière, Marc, Mathurin, Philippe, Dharancy, Sebastien, Blanc, Jean-Frédéric, Abergel, Armand, Chazouillères, Olivier, Mallat, Ariane, Grangé, Jean-Didier, Attali, Pierre, d’Alteroche, Louis, Wartelle, Claire, Dao, Thông, Thabut, Dominique, Pilette, Christophe, Silvain, Christine, Christidis, Christos, Nguyen-Khac, Eric, Bernard-Chabert, Brigitte, Hillaire, Sophie, Di Martino, Vincent

“…In this study we aimed to analyse the impact of the aetiology of cirrhosis on the incidence, characteristics and prognosis of hepatocellular carcinoma (HCC)…”
Get full text

Faldaprevir and Deleobuvir for HCV Genotype 1 Infection by Zeuzem, Stefan, Soriano, Vincent, Asselah, Tarik, Bronowicki, Jean-Pierre, Lohse, Ansgar W, Müllhaupt, Beat, Schuchmann, Marcus, Bourlière, Marc, Buti, Maria, Roberts, Stuart K, Gane, Ed J, Stern, Jerry O, Vinisko, Richard, Kukolj, George, Gallivan, John-Paul, Böcher, Wulf-Otto, Mensa, Federico J

“…In this phase 2b study, an interferon-free regimen consisting of the combination of a protease inhibitor (faldaprevir), a nonnucleoside polymerase inhibitor…”
Get full text

Real‐world economic burden of hepatitis C and impact of direct‐acting antivirals in France: A nationwide claims data analysis by Lam, Laurent, Carrieri, Patrizia, Hejblum, Gilles, Bellet, Jonathan, Bourlière, Marc, Carrat, Fabrice

“…Background and Aims The economic impact of managing patients with hepatitis C virus (HCV) infection remains unknown. This study aimed to assess the economic…”
Get full text

All-oral daclatasvir plus asunaprevir for hepatitis C virus genotype 1b: a multinational, phase 3, multicohort study by Manns, Michael, Prof, Pol, Stanislas, Prof, Jacobson, Ira M, Prof, Marcellin, Patrick, Prof, Gordon, Stuart C, Prof, Peng, Cheng-Yuan, MD, Chang, Ting-Tsung, Prof, Everson, Gregory T, Prof, Heo, Jeong, Prof, Gerken, Guido, Prof, Yoffe, Boris, Prof, Towner, William J, MD, Bourliere, Marc, MD, Metivier, Sophie, MD, Chu, Chi-Jen, MD, Sievert, William, Prof, Bronowicki, Jean-Pierre, Prof, Thabut, Dominique, Prof, Lee, Youn-Jae, Prof, Kao, Jia-Horng, Prof, McPhee, Fiona, PhD, Kopit, Justin, PhD, Mendez, Patricia, MD, Linaberry, Misti, MPH, Hughes, Eric, MD, Noviello, Stephanie, MD

“…Summary Background An unmet need exists for interferon-free and ribavirin-free treatments for chronic hepatitis C virus (HCV) infection. In this study, we…”
Get full text

Eradication of Hepatitis C Virus Infection in Patients With Cirrhosis Reduces Risk of Liver and Non-Liver Complications by Nahon, Pierre, Bourcier, Valérie, Layese, Richard, Audureau, Etienne, Cagnot, Carole, Marcellin, Patrick, Guyader, Dominique, Fontaine, Hélène, Larrey, Dominique, De Lédinghen, Victor, Ouzan, Denis, Zoulim, Fabien, Roulot, Dominique, Tran, Albert, Bronowicki, Jean-Pierre, Zarski, Jean-Pierre, Leroy, Vincent, Riachi, Ghassan, Calès, Paul, Péron, Jean-Marie, Alric, Laurent, Bourlière, Marc, Mathurin, Philippe, Dharancy, Sébastien, Blanc, Jean-Frédéric, Abergel, Armand, Serfaty, Lawrence, Mallat, Ariane, Grangé, Jean-Didier, Attali, Pierre, Bacq, Yannick, Wartelle, Claire, Dao, Thông, Benhamou, Yves, Pilette, Christophe, Silvain, Christine, Christidis, Christos, Capron, Dominique, Bernard-Chabert, Brigitte, Zucman, David, Di Martino, Vincent, Thibaut, Vincent, Salmon, Dominique, Ziol, Marianne, Sutton, Angela, Pol, Stanislas, Roudot-Thoraval, Françoise

“…Background & Aims We performed a prospective study to investigate the effects of a sustained viral response (SVR) on outcomes of patients with hepatitis C…”
Get full text

Retreatment with TACE: The ABCR SCORE, an aid to the decision-making process by Adhoute, Xavier, Penaranda, Guillaume, Naude, Sebastien, Raoul, Jean Luc, Perrier, Herve, Bayle, Olivier, Monnet, Olivier, Beaurain, Patrick, Bazin, Christophe, Pol, Bernard, Folgoc, Gaelle Le, Castellani, Paul, Bronowicki, Jean Pierre, Bourlière, Marc

“…Background & Aims Transarterial chemoembolization (TACE) is the standard of care for intermediate stage hepatocellular carcinoma (HCC) and it is the most…”
Get full text